Valuation : QuidelOrtho Corporation

Market Cap 1.02B 878M 824M 752M 1.42B 97.52B 1.43B 9.75B 3.78B 49.2B 3.84B 3.76B 163B P/E 2026 *
-3.62x
P/E 2027 * -5.38x
Enterprise Value 3.74B 3.21B 3.01B 2.75B 5.19B 356B 5.21B 35.61B 13.8B 180B 14.02B 13.72B 595B EV / Sales 2026 *
1.47x
EV / Sales 2027 * 1.41x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day+1.17%
1 week+2.15%
Current month-9.54%
1 month-9.86%
3 months+23.03%
6 months-33.29%
Current year-46.88%
1 week 14.11
Extreme 14.1055
15.5
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap.
8/15/26 A Fiscal year

EVP Global Port. Mgmt & Mkting

1,054 0.0015%
7/15/26 A Free

Chief Financial Officer

356,555 0.5251%
7/6/26 A Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%+2.15%-45.37%-80.35% 1.02B
+1.88%+0.08%+28.77%-29.37% 17.61B
+15.78%+0.07%-30.47%+110.64% 1.7B
+1.15%-1.48%-25.14%+23.04% 951M
+0.03%0.00%+61.48%-5.57% 779M
+2.67%+1.05%-38.28%-44.75% 690M
+3.43%-8.53%-44.27%-48.79% 550M
+1.85%+4.35%-38.26%-36.14% 452M
+2.07%+2.85%+68.97%+46.42% 429M
-0.85%+4.46%-7.98%-9.00% 410M
Average +2.87%+2.15%-7.06%-7.39% 2.46B
Weighted average by Cap. +2.70%+3.77%+15.89%-18.38%

Financials

2026 *2027 *
Net sales 2.54B 2.18B 2.05B 1.87B 3.53B 243B 3.55B 24.26B 9.4B 122B 9.55B 9.35B 406B 2.59B 2.22B 2.09B 1.91B 3.6B 247B 3.62B 24.71B 9.58B 125B 9.73B 9.52B 413B
Net income -282M -242M -227M -207M -391M -26.85B -393M -2.68B -1.04B -13.55B -1.06B -1.03B -44.87B -190M -163M -153M -140M -264M -18.15B -266M -1.81B -703M -9.16B -715M -699M -30.33B
Net Debt 2.71B 2.33B 2.19B 2B 3.77B 259B 3.78B 25.86B 10.02B 131B 10.19B 9.96B 432B 2.62B 2.25B 2.11B 1.93B 3.64B 250B 3.66B 25.02B 9.7B 126B 9.85B 9.64B 418B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
27/08/26 $15.10 +1.24% 32,085
26/08/26 $14.91 -0.93% 1,599,003
25/08/26 $15.05 +3.86% 987,350
24/08/26 $14.49 -1.70% 1,039,094
21/08/26 $14.74 -0.74% 2,022,153
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
14.91USD
Average target price
14.67USD
Spread / Average Target
-1.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock